Top Page
Cohort plc
(LSE:CHRT)
Cohort plc (CHRT) vs. iShares MSCI United Kingdom ETF (EWC)
Cohort plc Business Overview & Revenue Model
Cohort plc Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 270.04M | 270.04M | 202.53M | 182.71M | 137.76M | 143.31M |
| Gross Profit | 78.81M | 90.42M | 76.27M | 64.86M | 56.60M | 53.36M |
| EBITDA | 32.48M | 35.57M | 29.25M | 22.13M | 20.78M | 20.34M |
| Net Income | 19.25M | 19.25M | 15.32M | 11.36M | 9.20M | 5.46M |
Balance Sheet | ||||||
| Total Assets | 396.58M | 396.58M | 252.50M | 210.69M | 203.17M | 190.88M |
| Cash, Cash Equivalents and Short-Term Investments | 74.65M | 74.65M | 55.16M | 41.45M | 40.37M | 32.29M |
| Total Debt | 78.88M | 78.88M | 40.51M | 34.98M | 39.52M | 37.38M |
| Total Liabilities | 236.49M | 236.49M | 142.66M | 110.91M | 113.98M | 105.83M |
| Stockholders Equity | 158.61M | 158.61M | 108.67M | 97.02M | 83.97M | 79.31M |
Cash Flow | ||||||
| Free Cash Flow | 39.13M | 38.00M | 16.36M | 11.29M | 17.52M | 14.97M |
| Operating Cash Flow | 52.31M | 51.18M | 23.02M | 16.52M | 19.52M | 16.22M |
| Investing Cash Flow | -94.77M | -93.65M | -6.16M | -6.11M | -2.37M | -2.54M |
| Financing Cash Flow | 46.18M | 46.18M | -16.92M | -10.57M | -8.70M | -1.55M |
Cohort plc Technical Analysis
Cohort plc Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £617.76M | 30.04 | 14.40% | 1.20% | 33.33% | 19.01% | |
72 Outperform | 983.76M | 40.04 | 17.78% | 1.58% | 14.88% | 45.73% | |
71 Outperform | 1.51B | 38.88 | 11.09% | 1.40% | 8.00% | 674.47% | |
70 Outperform | 58.80B | 30.58 | 16.84% | 1.64% | 11.60% | 8.03% | |
69 Neutral | 604.46M | 119.21 | 1.80% | 0.91% | 14.69% | ― | |
56 Neutral | 2.86B | -15.64 | -29.64% | 1.66% | 1.02% | -240.44% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
Cohort plc Corporate Events
Cohort plc announced that its Chief Executive, Andrew Thomis, will be presenting an introduction to the company at MelloMonday on September 15, 2025, via a Zoom Webinar. This presentation aims to engage with potential investors and stakeholders, highlighting the company’s strategic initiatives and market positioning in the defense sector.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1335.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced changes in director shareholdings following the vesting of the Executive Long Term Incentive Plan 2021 share awards. The vested shares were transferred to executive directors at no cost, with a portion sold to cover tax and National Insurance liabilities. The remaining shares are subject to a two-year holding period. The vesting was based on performance conditions related to organic and total growth targets, which were exceeded. This announcement highlights Cohort’s strong performance and commitment to rewarding its executives, potentially impacting its market positioning positively.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1335.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced changes in director shareholdings, specifically the vesting and transfer of share awards to Andrew Thomis, the Chief Executive. This transaction highlights the company’s ongoing commitment to its executive compensation strategy, potentially impacting stakeholder perceptions and reinforcing its market position.
The most recent analyst rating on (GB:CHRT) stock is a Buy with a £1754.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc has announced its total voting rights as of 31 August 2025, with an issued share capital consisting of 46,805,622 ordinary shares, each carrying one vote. This update is in accordance with the FCA’s Disclosure Guidance and Transparency Rule, providing shareholders with the necessary information to calculate their interests in the company’s shares. This announcement ensures transparency and compliance with regulatory requirements, maintaining Cohort’s commitment to clear communication with its stakeholders.
The most recent analyst rating on (GB:CHRT) stock is a Buy with a £1754.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc has announced the release of its Annual Report and Accounts for the year ending April 30, 2025, along with the Notice of its Annual General Meeting (AGM), which will be held on September 25, 2025, in London. This announcement is significant for shareholders and stakeholders as it provides insights into the company’s financial performance and strategic direction, impacting its operations and positioning within the defense and related markets.
The most recent analyst rating on (GB:CHRT) stock is a Buy with a £1754.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced changes in director shareholdings, specifically the transfer of vested shares to Simon Walther, the Finance Director. This transfer, part of the 2013 Restricted Share Scheme, highlights the company’s ongoing commitment to aligning management interests with shareholder value. The transaction reflects a structured approach to executive compensation, potentially impacting stakeholder perceptions of the company’s governance and financial strategies.
The most recent analyst rating on (GB:CHRT) stock is a Buy with a £1570.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc has announced the grant of Long-Term Incentive Plan (LTIP) awards to its Chief Executive Officer, Andrew Thomis, and Finance Director, Simon Walther. These awards, comprising ordinary shares, are performance-related and will vest in August 2028, contingent on achieving growth targets. This move is part of Cohort’s strategy to align executive incentives with company performance, potentially enhancing its market position and stakeholder value.
The most recent analyst rating on (GB:CHRT) stock is a Buy with a £1570.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced its total voting rights as of July 31, 2025, with an issued share capital consisting of 46,719,342 ordinary shares, each carrying one vote. This information is crucial for shareholders to determine their interests in the company’s shares under the FCA’s Disclosure Guidance and Transparency Rules. The announcement reinforces Cohort’s commitment to transparency and regulatory compliance, impacting stakeholders by providing clarity on shareholding structures.
The most recent analyst rating on (GB:CHRT) stock is a Buy with a £1570.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced the sale of ordinary shares by its Chairman, Nick Prest, and Executive Directors, Andrew Thomis and Simon Walther, along with their closely associated persons. The transactions, conducted on July 16, 2025, involved a total of 560,102 shares sold at 1743.24 pence each. Despite these sales, the directors maintain their minimum shareholding requirements, ensuring their alignment with shareholder interests. This move reflects a routine adjustment in personal shareholdings and does not impact the company’s strategic direction or operational stability.
The most recent analyst rating on (GB:CHRT) stock is a Buy with a £1570.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.